ReviewLife (Basel, Switzerland)2023

Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives.

Dong-Ho NahmPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.